Logo image of ANAT

AMERICAN NATIONAL GROUP INC (ANAT) Stock Fundamental Analysis

NASDAQ:ANAT - Nasdaq - US02772A1097 - Common Stock

190.02  +0.34 (+0.18%)

After market: 189.61 -0.41 (-0.22%)

Fundamental Rating

1

Taking everything into account, ANAT scores 1 out of 10 in our fundamental rating. ANAT was compared to 143 industry peers in the Insurance industry. ANAT has a bad profitability rating. Also its financial health evaluation is rather negative. ANAT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ANAT had positive earnings in the past year.
ANAT Yearly Net Income VS EBIT VS OCF VS FCFANAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

1.2 Ratios

Industry RankSector Rank
ROA 2.06%
ROE 9.49%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANAT Yearly ROA, ROE, ROICANAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

ANAT does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 16.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANAT Yearly Profit, Operating, Gross MarginsANAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 5 10 15

More info and screens

1

2. Health

2.1 Basic Checks

ANAT has less shares outstanding than it did 1 year ago.
The debt/assets ratio for ANAT has been reduced compared to a year ago.
ANAT Yearly Shares OutstandingANAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
ANAT Yearly Total Debt VS Total AssetsANAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 10B 20B 30B

2.2 Solvency

ANAT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
ANAT Yearly LT Debt VS Equity VS FCFANAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

2

3. Growth

3.1 Past

ANAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.33%.
ANAT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.98% yearly.
ANAT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.93%.
Measured over the past years, ANAT shows a small growth in Revenue. The Revenue has been growing by 3.97% on average per year.
EPS 1Y (TTM)-25.33%
EPS 3Y63.4%
EPS 5Y29.98%
EPS Q2Q%-34.86%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y4.7%
Revenue growth 5Y3.97%
Sales Q2Q%2.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ANAT Yearly Revenue VS EstimatesANAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ANAT is valuated reasonably with a Price/Earnings ratio of 8.02.
ANAT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.21.
Industry RankSector Rank
PE 8.02
Fwd PE N/A
ANAT Price Earnings VS Forward Price EarningsANAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.12
ANAT Per share dataANAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.27
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

ANAT has a Yearly Dividend Yield of 1.74%. Purely for dividend investing, there may be better candidates out there.
Compared to the average S&P500 Dividend Yield of 2.42, ANAT is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.74%

5.2 History

ANAT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0%
Div Incr YearsN/A
Div Non Decr YearsN/A
ANAT Yearly Dividends per shareANAT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 1 2 3

5.3 Sustainability

ANAT pays out 13.86% of its income as dividend. This is a sustainable payout ratio.
DP13.86%
EPS Next 2YN/A
EPS Next 3YN/A
ANAT Yearly Income VS Free CF VS DividendANAT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M
ANAT Dividend Payout.ANAT Dividend Payout, showing the Payout Ratio.ANAT Dividend Payout.PayoutRetained Earnings

More info and screens

AMERICAN NATIONAL GROUP INC

NASDAQ:ANAT (5/24/2022, 8:21:25 PM)

After market: 189.61 -0.41 (-0.22%)

190.02

+0.34 (+0.18%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-24 2022-05-24/dmh
Earnings (Next)08-01 2022-08-01
Inst Owners0%
Inst Owner Change0%
Ins Owners2.5%
Ins Owner Change0%
Market Cap5.11B
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.74%
Yearly Dividend3.28
Dividend Growth(5Y)0%
DP13.86%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.02
Fwd PE N/A
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB N/A
EV/EBITDA 8.12
EPS(TTM)23.69
EY12.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS147.35
BVpS249.54
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.27
Profitability
Industry RankSector Rank
ROA 2.06%
ROE 9.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 16.07%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.33%
EPS 3Y63.4%
EPS 5Y29.98%
EPS Q2Q%-34.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.93%
Revenue growth 3Y4.7%
Revenue growth 5Y3.97%
Sales Q2Q%2.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A